We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division ... Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. Show more
Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) on Wednesday, May 29th, at the New York Hilton Midtown, New York, NY...
Paramount Global (NASDAQ:PARA), Sony (NYSE:SONY), Apollo Global Management (NYSE:APO) – Sony Pictures Entertainment and Apollo Global Management are in discussions for a joint bid for...
U.S. index futures displayed positive performance in pre-market trading on Wednesday, with S&P 500 aiming to halt a downward trend that persisted over the last three consecutive days. As of...
Stocks showed a lack of direction over the course of the trading day on Tuesday, as traders took a breather following the sell-off seen over the two previous sessions. The major averages bounced...
2024 First-Quarter reported sales growth of 2.3% to $21.4 Billion with operational growth of 3.9%* and adjusted operational growth of 4.0%* Adjusted operational growth excluding COVID-19 Vaccine...
Johnson & Johnson (NYSE:JNJ) reported a robust start to fiscal 2024, with a 2.3% increase in first-quarter sales, reaching $21.4 billion. This financial uptick comes after the company’s...
The major U.S. index futures are currently pointing to higher open on Tuesday, with stocks likely to regain ground after moving sharply lower over the two previous sessions. Bargain hunting may...
U.S. index futures are mixed in pre-market trading this Tuesday, with the Dow Jones aiming to break a six-day losing streak. At 6:26 AM, the Dow Jones futures (DOWI:DJI) were up 65 points, or...
Live Nation Entertainment (NYSE:LYV) – The U.S. Department of Justice plans to initiate an antitrust lawsuit against Live Nation next month, citing its control over the live event market...
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.11 | -0.075337305664 | 146.01 | 150.49 | 144.54 | 9473212 | 148.47243734 | CS |
4 | -11.97 | -7.5821878761 | 157.87 | 158.15 | 143.13 | 8132609 | 149.29780188 | CS |
12 | -12.07 | -7.64069127049 | 157.97 | 163.11 | 143.13 | 7714043 | 155.17380884 | CS |
26 | -5.73 | -3.77893556684 | 151.63 | 163.58 | 143.13 | 7251944 | 155.16177854 | CS |
52 | -18.19 | -11.0853799744 | 164.09 | 175.97 | 143.13 | 10983219 | 162.61205798 | CS |
156 | -19.31 | -11.6881544701 | 165.21 | 186.69 | 143.13 | 8457481 | 165.95296028 | CS |
260 | 6.02 | 4.30368887618 | 139.88 | 186.69 | 109.16 | 8165001 | 157.5415444 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions